Neurocrine Biosciences (NBIX) Prepaid Assets (2010 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Prepaid Assets of $217.1 million for Q2 2026, up 79.87% year-over-year from $120.7 million in Q2 2025, and down 3.43% on a QoQ basis from $224.8 million in Q1 2026.
Neurocrine Biosciences (NBIX) Prepaid Assets (2010 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Prepaid Assets for 17 years, with the latest figure at $217.1 million in Q2 2026.
- Prepaid Assets for Q2 2026 came in at $217.1 million, up 79.87% year-over-year; the trailing twelve-month figure through Jun 2026 was $217.1 million (up 79.87% YoY), and the FY2025 annual result was $170.7 million, up 168.4% from the prior year.
- Prepaid Assets fell to $217.1 million in Q2 2026, from $224.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $224.8 million in Q1 2026 and troughed at $60.8 million in Q1 2022.
- A 5-year average of $118.2 million and a median of $110.7 million in 2023 frame the typical range for Prepaid Assets.
- The widest annual swing landed in 2024, when Prepaid Assets slumped 34.97%; it then surged 168.4% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $79.1 million in 2022, then rose by 23.64% to $97.8 million in 2023, then slumped by 34.97% to $63.6 million in 2024, then soared by 168.4% to $170.7 million in 2025, then rose by 27.18% to $217.1 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $217.1 million in Q2 2026, $224.8 million in Q1 2026, and $170.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 217.10 Mn |
| Mar 31, 2026 | 224.80 Mn |
| Dec 31, 2025 | 170.70 Mn |
| Sep 30, 2025 | 68.20 Mn |
| Jun 30, 2025 | 120.70 Mn |
| Mar 31, 2025 | 119.30 Mn |
| Dec 31, 2024 | 63.60 Mn |
| Sep 30, 2024 | 121.70 Mn |
| Jun 30, 2024 | 120.20 Mn |
| Mar 31, 2024 | 100.50 Mn |
| Dec 31, 2023 | 97.80 Mn |
| Sep 30, 2023 | 108.20 Mn |
| Jun 30, 2023 | 100.60 Mn |
| Mar 31, 2023 | 113.20 Mn |
| Dec 31, 2022 | 79.10 Mn |
| Sep 30, 2022 | 67.90 Mn |
| Jun 30, 2022 | 62.70 Mn |
| Mar 31, 2022 | 60.80 Mn |
| Dec 31, 2021 | 45.50 Mn |
| Sep 30, 2021 | 50.50 Mn |